G.P.6.01 Establishing the parameters for clinical trials of antisense oligonucleotide therapy in Duchenne muscular dystrophy
| Autor: | Kinali, M., Arechavala-Gomeza, V., Feng, L., Glover, A., Guglieri, M., Jungbluth, H., Roper, H., Quinlivan, R.M., Hunt, D., Manzur, A.M., Henderson, A., Gosalakkal, J., Hollingsworth, K., Allsop, J., Mercuri, E., Morgan, J., Sewry, C., Straub, V., Bushby, K., Rutherford, M., Muntoni, F. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2008 18(9-10):773-773 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect